Clinical Trial Update: An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial to reduce cellular senescence and improve frailty in adult survivors of childhood cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Cancer
• Frailty Syndrome

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Frailty, Childhood Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING